Effect of Stem Cell Source and Dose on Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Idiopathic Aplastic Anemia: Data from the Korean Aplastic Anemia Trials
Hawk Kim(Ulsan College), Yunsuk Choi(University of Ulsan), Sung Hwa Bae(Daegu Catholic University Medical Center), Kyoo‐Hyung Lee(Asan Medical Center), Sung‐Hyun Kim(Dong-A University), Inho Kim(Seoul National University), Min Kyoung Kim(Yeungnam University), Jung Hye Choi(Hanyang University Guri Hospital), Won Sik Lee(Fred Hutch Cancer Center), Jae‐Yong Kwak(Jeonbuk National University Hospital), Ho‐Jin Shin(Pusan National University Hospital), Jong-Ho Won(Soonchunhyang University Hospital Seoul), Yong Park(Ewha Womans University), Sang Kyun Sohn(Kyungpook National University Hospital)
Cited by 7
Related Papers
Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial
|The Lancet Oncology|2020|401
Targeting c-KIT (CD117) by dasatinib and radotinib promotes acute myeloid leukemia cell death
|Scientific Reports|2017|70
Canine Bone Marrow-Derived Mesenchymal Stromal Cells Suppress Alloreactive Lymphocyte Proliferation in Vitro but Fail to Enhance Engraftment in Canine Bone Marrow Transplantation
|Biology of Blood and Marrow Transplantation|2010|65